Silk Road Medical Inc
NASDAQ:SILK
Intrinsic Value
Silk Road Medical, Inc. develops and manufactures medical devices to treat neurovascular diseases. [ Read More ]
The intrinsic value of one SILK stock under the Base Case scenario is 20.63 USD. Compared to the current market price of 17.46 USD, Silk Road Medical Inc is Undervalued by 15%.
Valuation Backtest
Silk Road Medical Inc
Run backtest to discover the historical profit from buying and selling SILK stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Silk Road Medical Inc
Current Assets | 240.8m |
Cash & Short-Term Investments | 181.5m |
Receivables | 23.6m |
Other Current Assets | 35.8m |
Non-Current Assets | 24.5m |
Long-Term Investments | 9.5m |
PP&E | 14.6m |
Other Non-Current Assets | 415k |
Current Liabilities | 30.3m |
Accounts Payable | 5.7m |
Accrued Liabilities | 24.5m |
Other Current Liabilities | 143k |
Non-Current Liabilities | 83.9m |
Long-Term Debt | 75.6m |
Other Non-Current Liabilities | 8.2m |
Earnings Waterfall
Silk Road Medical Inc
Revenue
|
177.1m
USD
|
Cost of Revenue
|
-50m
USD
|
Gross Profit
|
127.1m
USD
|
Operating Expenses
|
-186.4m
USD
|
Operating Income
|
-59.3m
USD
|
Other Expenses
|
3.5m
USD
|
Net Income
|
-55.7m
USD
|
Free Cash Flow Analysis
Silk Road Medical Inc
What is Free Cash Flow?
SILK Profitability Score
Profitability Due Diligence
Silk Road Medical Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Score
Silk Road Medical Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
SILK Solvency Score
Solvency Due Diligence
Silk Road Medical Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Score
Silk Road Medical Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SILK Price Targets Summary
Silk Road Medical Inc
According to Wall Street analysts, the average 1-year price target for SILK is 20.57 USD with a low forecast of 8.08 USD and a high forecast of 29.4 USD.
Ownership
SILK Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
SILK Price
Silk Road Medical Inc
Average Annual Return | 13.32% |
Standard Deviation of Annual Returns | 29.69% |
Max Drawdown | -91% |
Market Capitalization | 683.8m USD |
Shares Outstanding | 39 174 600 |
Percentage of Shares Shorted | 10.63% |
SILK News
Last Important Events
Silk Road Medical Inc
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Silk Road Medical Inc
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Silk Road Medical, Inc. develops and manufactures medical devices to treat neurovascular diseases. The company is headquartered in Sunnyvale, California and currently employs 352 full-time employees. The company went IPO on 2019-04-04. The firm has discovered an approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR), which relies on two concepts: minimally invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain and combines the benefits of innovative endovascular techniques with fundamental surgical principles. The firm's ENROUTE Transcarotid Neuroprotection System (NPS) and ENROUTE Transcarotid Stent System are the products for use in TCAR. Its ENROUTE Transcarotid Stent System is placed during a period of temporary high-rate blood flow reversal, which is enabled by its ENROUTE Transcarotid NPS. The company markets and sells its products in the United States through a direct sales organization consisting of approximately 64 sales representatives and 62 clinical support specialists.
Contact
IPO
Employees
Officers
The intrinsic value of one SILK stock under the Base Case scenario is 20.63 USD.
Compared to the current market price of 17.46 USD, Silk Road Medical Inc is Undervalued by 15%.